Clinical

Researchers from University of Pittsburgh and UPMC say they're encouraged by what may one day be a new tool to help battle cancer and heart disease: an ultrasound-enabled genetic therapy called sonoporation.

The U.S Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response has awarded $2.6 million to DiaSorin – an Italy-based biotechnology company with offices in Stillwater, Minnesota – to further develop its Zika diagnostic tool.

Fine print of many marketplace health plan documents allows them to refuse a range of services, disproportionately affecting women, study says.

By helping spot gene-based drug interactions, Translational Software says the interface could spur more routine clinical use of genomic data.

Patients claim they take responsibility for their own health. Doctors don’t believe that. The discrepancy means clinicians have an opportunity to improve communication to better partner with their patients.

Twenty one hospitals will use the supercomputer and the Watson for Oncology software piloted by Memorial Sloan Kettering in New York to offer personalized care for cancer patients.

The startup’s technology platform combines data science with analytics, clinical expertise, mobile tools to create personalization and engagement, CEO Rajeev Singh said.

The diagnostic and imaging company will use the funding to advance development of technology for testing blood supplies for the Zika virus.

The university aims to make genetic testing a regular part of healthcare using Google's Cloud Platform and informatics.

OpenNotes Executive Director Catherine DesRoches said the growing number of patients able to access their medical records online is advancing the shift toward transparency between doctors and patients.